About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Antipsychotic drugs
- Company
- Université de Sherbrooke
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 33 recruiting
Efficacy results: Not yet reported
33 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 27, 2026
Find a Clinical Trial Near Me
See recruiting studies for Antipsychotic drugs and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02640911
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
Shanghai Mental Health Center 3000 participants Est. completion 2033-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT03911726
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
Not yet reported Central Institute of Mental Health, Mannheim 140 participants Est. completion 2028-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT04370730
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
Not yet reported Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2026-10-01 6 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Recruiting NCT NCT04373317
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Not yet reported VA Office of Research and Development 358 participants Est. completion 2028-08-24 24 sitesOther conditions: Parkinson's Disease PsychosisView official trial listing → -
Recruiting NCT NCT04478838
"Extended" (Alternate Day) Antipsychotic Dosing
Not yet reported Centre for Addiction and Mental Health 120 participants Est. completion 2028-09-30 1 siteOther conditions: Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy, Antipsychotic AgentsView official trial listing → -
Recruiting NCT NCT05603104
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Not yet reported Dr. Inge Winter 1254 participants Est. completion 2028-06-30 1 siteOther conditions: Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar DepressionView official trial listing → -
Recruiting NCT NCT05728138
Psychosocial Intervention for Suicidal Ideation in Individuals With FEP: A Feasibility Trial
Not yet reported Pakistan Institute of Living and Learning 80 participants Est. completion 2025-10-30 1 siteOther conditions: Self Harm, First Episode PsychosisView official trial listing → -
Recruiting NCT NCT05744479
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
Not yet reported Centre for Addiction and Mental Health 100 participants Est. completion 2027-03-01 1 siteOther conditions: Intellectual Disability, Developmental Disability, ObesityView official trial listing → -
Recruiting NCT NCT05796401
Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis
Not yet reported Centre Hospitalier St Anne 500 participants Est. completion 2029-02-15 13 sitesOther conditions: PsychosisView official trial listing → -
Recruiting NCT NCT05942716
Serotonin Control of Impulsivity in Tourette Disorder
Not yet reported Hospices Civils de Lyon 25 participants Est. completion 2028-09-24 2 sitesOther conditions: Tourette DisorderView official trial listing → -
Recruiting NCT NCT05951660
Sex, Psychopharmacology, and Diabetes
Not yet reported Zealand University Hospital 256 participants Est. completion 2025-07-31 1 sitePrediabetes Other conditions: Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Diabetes Mellitus, Sexual Dysfunction, Drug-Related Side Effects and Adverse Reactions, EducationView official trial listing → -
Recruiting NCT NCT05999240
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Not yet reported New York State Psychiatric Institute 30 participants Est. completion 2027-12-31 2 sitesOther conditions: Autism Spectrum DisorderView official trial listing → -
Recruiting NCT NCT06123897
Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study
Central South University 2000 participants Est. completion 2028-12-31 4 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06431009
The Danish Region Midt Schizophrenia Cohort
University of Aarhus 350 participants Est. completion 2026-12-31 5 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06456983
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Not yet reported Central Institute of Mental Health, Mannheim 140 participants Est. completion 2028-07 14 sitesOther conditions: Schizophrenia, Treatment Resistant SchizophreniaView official trial listing → -
Recruiting NCT NCT06482554
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Not yet reported Louisiana State University Health Sciences Center Shreveport 80 participants Est. completion 2026-12 1 siteOther conditions: Apathy, Schizophrenia, Schizophrenia; PsychosisView official trial listing → -
Recruiting NCT NCT06560957
SYNCED - SYNChronized Eating in Bipolar Depression Study
Not yet reported University of Ottawa 40 participants Est. completion 2027-02-26 1 siteOther conditions: Bipolar Depression, Bipolar I Disorder, Bipolar II DisorderView official trial listing → -
Recruiting NCT NCT06580860
Psychiatric Multi-omics and Neuroimaging Project
mingjun Zhong 1899 participants Est. completion 2027-01 1 siteOther conditions: Mental Disorders, Healthy ControlView official trial listing → -
Recruiting NCT NCT06651112
The ATP Project (Antipsychotic-TEP-Psychosis)
Université de Sherbrooke 18 participants Est. completion 2028-06-01 1 siteOther conditions: First Episose Psychosis, Metabolic Disease, Psychosis; EpisodeView official trial listing → -
Recruiting NCT NCT06729671
A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction
Not yet reported University College Cork 70 participants Est. completion 2026-11-30 2 sitesOther conditions: PsychosisView official trial listing → -
Recruiting NCT NCT06754319
Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis
Shanghai Mental Health Center 125 participants Est. completion 2027-12-31 1 siteOther conditions: Obsessive-Compulsive Disorder, Tic DisorderView official trial listing → -
Recruiting NCT NCT06756139
Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia
Not yet reported Air Force Military Medical University, China 88 participants Est. completion 2025-11-01 7 sitesOther conditions: Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic DrugView official trial listing → -
Recruiting NCT NCT06814314
AP Metabolism Transcriptomics
IRCCS Eugenio Medea 100 participants Est. completion 2026-05 1 siteOther conditions: Neurodevelopmental Disorders, IrritabilityView official trial listing → -
Recruiting NCT NCT06831942
Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA): An Evaluation of a Psychosocial Intervention for Suicidal Adults Aged 65+
Not yet reported Vastra Gotaland Region 132 participants Est. completion 2031-06 2 sitesOther conditions: Suicidal Ideation, Suicide Attempt, SuicideView official trial listing → -
Recruiting NCT NCT06936137
: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)
Not yet reported Ain Shams University 180 participants Est. completion 2026-12-20 1 siteOther conditions: Antipsychotic Induced Weight GainView official trial listing → -
Recruiting NCT NCT06961968
Randomized Withdrawal Study in Patients With Schizophrenia
Not yet reported Vanda Pharmaceuticals 400 participants Est. completion 2027-11 22 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06997198
Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Not yet reported University Hospitals Cleveland Medical Center 25 participants Est. completion 2027-10-01 1 siteOther conditions: Tardive Dyskinesia, Intellectual Disability, Developmental DisabilitiesView official trial listing → -
Recruiting NCT NCT07001878
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
Not yet reported Nova Scotia Health Authority 24 participants Est. completion 2026-12-01 2 sitesOther conditions: Psychosis, Cannabis UseView official trial listing → -
Recruiting NCT NCT07025590
Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
Not yet reported Guangdong Provincial People's Hospital 106 participants Est. completion 2027-03-31 1 siteCardiovascular disease Other conditions: Depression Anxiety DisorderView official trial listing → -
Recruiting NCT NCT07085923
Norwegian Mental Illness Heart Health Study
Not yet reported Madeleine Elisabeth Angelsen 70 participants Est. completion 2028-06-30 1 siteMetabolic syndrome Other conditions: Cardio Vascular Disease, Severe Mental Disorder, Schizophrenia and Schizophrenia Spectrum Psychosis, Bipolar Disease Type I, Overweight and/or Obesity, CVD Risk Factors, Severe Mental IllnessView official trial listing → -
Recruiting NCT NCT07139171
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Tianjin Anding Hospital 300 participants Est. completion 2025-12-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT07184619
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Not yet reported Newron Pharmaceuticals SPA 400 participants Est. completion 2027-03-31 19 sitesOther conditions: Treatment-resistant SchizophreniaView official trial listing → -
Recruiting NCT NCT07402928
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease
Danish Research Centre for Magnetic Resonance 140 participants Est. completion 2027-06-30 1 siteOther conditions: Healthy, Parkinson, Medication AdministrationView official trial listing → -
Completed NCT NCT00000371
Trial of D-Cycloserine in Schizophrenia
Not yet reported Massachusetts General Hospital 60 participants Est. completion 2002-04Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00000373
Treatment of Obsessive-Compulsive Disorder
Not yet reported University of Florida 74 participants Est. completion 2003-07 2 sitesOther conditions: Obsessive-Compulsive DisorderView official trial listing → -
Completed NCT NCT00000374
Treatment for First-Episode Schizophrenia
Not yet reported Northwell Health 125 participants Est. completion 2007-05 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00014001
CATIE- Schizophrenia Trial
Not yet reported National Institute of Mental Health (NIMH) 1600 participants Est. completion 2004-12 54 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00018668
Antipsychotic Response in Schizophrenia
Not yet reported US Department of Veterans Affairs Est. completion 2004-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00044655
Switching Medication to Treat Schizophrenia
Not yet reported Icahn School of Medicine at Mount Sinai 219 participants Est. completion 2009-03Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00044681
A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 258 participants Est. completion 2004-03Other conditions: Depressive Disorder, Depressive Disorder, Major, DepressionView official trial listing → -
Completed NCT NCT00057135
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness
Not yet reported US Department of Veterans Affairs 150 participants Est. completion 2006-09 5 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00065273
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 50 participants Est. completion 2001-06 1 siteOther conditions: Mental Retardation, Developmental Delay DisorderView official trial listing → -
Completed NCT NCT00065286
Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Est. completion 1999-11 2 sitesOther conditions: AkathisiaView official trial listing → -
Completed NCT NCT00074477
Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250 participants Est. completion 2004-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00083668
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 619 participants Est. completion 2005-05Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00096863
The MIND Study: Modifying the INcidence of Delirium
Not yet reported Vanderbilt University 102 participants Est. completion 2007-07 5 sitesOther conditions: Delirium, Cognition DisordersView official trial listing → -
Completed NCT NCT00101634
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 518 participants Est. completion 2006-03Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00107939
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
Not yet reported Novartis Pharmaceuticals 453 participants Est. completion 2007-04 22 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00122070
Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
Not yet reported University of Medicine and Dentistry of New Jersey 15 participants Est. completion 2008-05 1 siteOther conditions: Borderline Personality DisorderView official trial listing → -
Completed NCT NCT00137020
Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 294 participants Est. completion 2006-04 27 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00140426
A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
Not yet reported University of Colorado, Denver 41 participants Est. completion 2009-12 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT00144027
Patient-Centered Medication Adherence Intervention for Schizophrenia
Not yet reported US Department of Veterans Affairs 75 participants Est. completion 2009-07 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00156637
A Study of Strategies to Improve Schizophrenia Treatment
Not yet reported US Department of Veterans Affairs 106 participants Est. completion 2008-03 4 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Status unknown NCT NCT00157378
Optimization of Acute Treatment in First Episode Schizophrenia
Not yet reported Ludwig-Maximilians - University of Munich 300 participants Est. completion 2004-12 1 siteOther conditions: Schizophrenia, First-EpisodeView official trial listing → -
Completed NCT NCT00159120
Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
Not yet reported Heinrich-Heine University, Duesseldorf 71 participants Est. completion 2006-06 1 siteOther conditions: Schizophrenia, PsychosesView official trial listing → -
Completed NCT NCT00159133
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
Not yet reported Heinrich-Heine University, Duesseldorf 71 participants Est. completion 2006-06 1 siteOther conditions: Schizophrenia, PsychosesView official trial listing → -
Terminated NCT NCT00159757
12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 150 participants Est. completion 2005-02 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00159770
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290 participants Est. completion 2004-09 43 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT00161031
Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
Not yet reported University of Maryland, Baltimore 30 participants Est. completion 2006-12 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00167154
Risperidone and Suicidality in Major Depressive Disorder
Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2008-08 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00167310
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
Not yet reported University of Pittsburgh 57 participants Est. completion 2015-12 1 siteCardiovascular disease Other conditions: Schizophrenia, Schizoaffective Disorder, Major Depression, Bipolar DisorderView official trial listing → -
Terminated NCT NCT00169026
Alcoholism and Schizophrenia: Effects of Clozapine
Not yet reported Dartmouth-Hitchcock Medical Center 64 participants Est. completion 2004-01 1 siteOther conditions: Schizophrenia, Dual Diagnosis, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol AbuseView official trial listing → -
Completed NCT NCT00169702
The Effect of a Weight Management Program During Treatment With Olanzapine
Not yet reported Heinrich-Heine University, Duesseldorf 100 participants Est. completion 2007-07 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00169988
Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
Not yet reported Northwell Health 8 participants Est. completion 2007-04 1 siteOther conditions: Prodromal Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00174200
Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone
Not yet reported Pfizer 20 participants Est. completion 2006-05 3 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00175955
Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
Not yet reported UCB Pharma 70 participants Est. completion 2005-12 7 sitesOther conditions: Dyskinesia, Medication-inducedView official trial listing → -
Completed NCT NCT00176202
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Not yet reported University of Illinois at Chicago 65 participants Est. completion 2008-01 3 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00177164
Risperdal Consta for Bipolar Disorder
Not yet reported University of Pittsburgh 50 participants Est. completion 2009-12 4 sitesOther conditions: Bipolar I DisorderView official trial listing → -
Completed NCT NCT00178958
Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia
Not yet reported Northwestern University 70 participants Est. completion 2006-06Other conditions: Schizophrenia, Schizoaffective, Bipolar DisorderView official trial listing → -
Completed NCT NCT00179062
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
Not yet reported Vanderbilt University 300 participants Est. completion 2007-06 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Depressive Disorder, Major, Bipolar DisorderView official trial listing → -
Status unknown NCT NCT00182494
Diabetes Prevention Program in Schizophrenia [DPPS]
Not yet reported Hamilton Health Sciences Corporation 200 participants Est. completion 2009-01 1 siteOther conditions: Diabetes Mellitus, SchizophreniaView official trial listing → -
Completed NCT NCT00183625
Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients
Not yet reported University of California, Los Angeles 107 participants Est. completion 2006-09 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00188942
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Not yet reported University Health Network, Toronto 42 participants Est. completion 2009-06 2 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00191555
Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment
Not yet reported Eli Lilly and Company 360 participants Est. completion 2006-05 62 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00191828
A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme
Not yet reported Eli Lilly and Company 60 participants Est. completion 2005-08 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00194038
Aripiprazole in Late Life Bipolar Disorder
Not yet reported University Hospitals Cleveland Medical Center 20 participants Est. completion 2006-06Other conditions: Bipolar DisorderView official trial listing → -
Status unknown NCT NCT00197834
Study of Depakote for Behavioral and Psychological Symptoms in Dementia
Not yet reported Hearthstone Alzheimer Care 20 participants 1 siteOther conditions: DementiaView official trial listing → -
Status unknown NCT NCT00201292
Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
National Health Research Institutes, Taiwan 1350 participants Est. completion 2008-10 3 sitesMetabolic syndrome Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00202280
Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication
Not yet reported, Not yet reported Melbourne Health 120 participants Est. completion 2009-06 1 siteOther conditions: First Episode PsychosisView official trial listing → -
Completed NCT NCT00202293
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
Not yet reported Melbourne Health 83 participants Est. completion 2015-11-01 1 siteOther conditions: Bipolar Disorder, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00206570
Clinical Estradiol Trial in Women With Schizophrenia
Not yet reported Bayside Health 100 participants Est. completion 2004-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00208533
Aripiprazole in Children With Autism: A Pilot Study
Not yet reported Drexel University College of Medicine 11 participants Est. completion 2011-11-16 1 siteOther conditions: AutismView official trial listing → -
Completed NCT NCT00210548
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 366 participants Est. completion 2006-06Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00210717
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 748 participants Est. completion 2007-04Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00210769
A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203 participants Est. completion 2005-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00215150
Geodon for the Treatment of Refractory Social Anxiety Disorder
Not yet reported Duke University 51 participants Est. completion 2009-07 2 sitesOther conditions: Social Anxiety DisorderView official trial listing → -
Completed NCT NCT00215254
Quetiapine in Social Anxiety Disorder
Not yet reported, Not yet reported Duke University 15 participants Est. completion 2006-02 1 siteOther conditions: Social Anxiety DisorderView official trial listing → -
Completed NCT NCT00222807
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
University of Pittsburgh 200 participants Est. completion 2016-03 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Delusional DisorderView official trial listing → -
Completed NCT NCT00222833
The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
Not yet reported University of Pittsburgh 30 participants Est. completion 2005-12 1 siteCardiovascular disease Other conditions: Overweight, HyperlipidemiaView official trial listing → -
Completed NCT NCT00230893
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
Tuscaloosa Research & Education Advancement Corporation 99 participants Est. completion 2005-09 1 siteOther conditions: PTSD, Post-Traumatic Stress DisorderView official trial listing → -
Completed NCT NCT00236457
A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629 participants Est. completion 2002-12Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00236587
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100 participants Est. completion 2004-02Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00237861
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
Not yet reported Yale UniversityOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00245206
Side Effects of Newer Antipsychotics in Older Adults
Not yet reported Veterans Medical Research Foundation 406 participants Est. completion 2010-10 1 siteOther conditions: Schizophrenia, Alzheimer's Disease, DementiaView official trial listing → -
Completed NCT NCT00249132
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
Not yet reported Janssen, LP 523 participants Est. completion 1991-07Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00249223
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
Not yet reported Janssen Pharmaceutica N.V., Belgium 641 participants Est. completion 2000-12Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00250367
A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
Not yet reported Janssen Pharmaceutica N.V., Belgium 151 participants Est. completion 1999-11Other conditions: Bipolar Disorder, Manic DisorderView official trial listing → -
Completed NCT NCT00253136
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
Not yet reported Janssen, LP 458 participants Est. completion 2000-12Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00253149
A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 158 participants Est. completion 1999-04Other conditions: Bipolar Disorders, Manic DisorderView official trial listing → -
Completed NCT NCT00254202
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Not yet reported Vanda Pharmaceuticals 593 participants Est. completion 2007-03-21 42 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00255879
Movement Disorders Caused by Antipsychotic Drugs in Older Patients
Not yet reported University of California, San Diego 250 participants Est. completion 2004-08 1 siteOther conditions: Dyskinesia, Drug-InducedView official trial listing → -
Completed NCT NCT00264069
ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry
Janssen-Cilag, S.A. 2622 participants Est. completion 2006-06Other conditions: Schizophrenia, Bipolar Disorder, Depression, Personality DisorderView official trial listing → -
Terminated NCT NCT00272025
Treatment Resistant Bipolar Depression
Not yet reported Queen's University 1 participants Est. completion 2010-01 1 siteOther conditions: Bipolar DepressionView official trial listing → -
Terminated NCT NCT00287027
Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
National Alliance on Mental Illness New Hampshire 60 participants Est. completion 2006-12 1 siteOther conditions: Psychotic DisordersView official trial listing → -
Terminated NCT NCT00287742
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
Not yet reported Janssen Pharmaceutical K.K. 33 participants Est. completion 2003-03Other conditions: Alzheimer's Disease, DementiaView official trial listing → -
Completed NCT NCT00288366
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Not yet reported Northwestern University 49 participants Est. completion 2008-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00292370
Quetiapine Augmentation for Treatment-resistant PTSD
Not yet reported VA Office of Research and Development 124 participants Est. completion 2009-05 3 sitesOther conditions: Combat Disorders, Stress Disorders, Post-TraumaticView official trial listing → -
Completed NCT NCT00294008
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
Janssen Korea, Ltd., Korea 230 participants Est. completion 2009-06Other conditions: Schizophrenia, Tranquilizing Agents, Mental Disorders, Therapeutic Uses, Physiological Effects of Drugs, Psychotropic Drugs, Antipsychotic AgentsView official trial listing → -
Completed NCT NCT00304616
SWitching to Abilify Trial (SWAT)
Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 500 participants Est. completion 2007-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00309413
A Clinical Trial on the Antipsychotic Properties of Cannabidiol
Not yet reported University of Cologne 29 participants Est. completion 2008-07 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00309452
Specialized Treatment Early in Psychosis (STEP)
Not yet reported Yale University 120 participants Est. completion 2013-08 1 siteOther conditions: Schizophrenia and Disorders With Psychotic FeaturesView official trial listing → -
Terminated NCT NCT00314613
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
Not yet reported Duke University 30 participants 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00334035
Antipsychotic Therapy and First Episode
Not yet reported The University of Hong Kong 169 participants Est. completion 2007-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00344500
Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications
Not yet reported VA Office of Research and Development 122 participants Est. completion 2009-09 1 siteOther conditions: Diabetes, Obesity, Weight GainView official trial listing → -
Completed NCT NCT00347425
Switch Study of Existing Atypical Antipsychotics to Bifeprunox
Not yet reported Solvay Pharmaceuticals 286 participants Est. completion 2008-02 122 sitesOther conditions: Schizophrenia and Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00357006
A Definitive Estrogen Patch Study (ADEPT)
Not yet reported The Alfred 180 participants Est. completion 2013-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)View official trial listing → -
Completed NCT NCT00361166
Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
Not yet reported ACADIA Pharmaceuticals Inc. 400 participants Est. completion 2007-03 17 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00363181
Side Effects of Antipsychotic Medications
Stanford University 76 participants Est. completion 2011-12 1 siteMetabolic syndrome Other conditions: Insulin Resistance, Schizophrenia and Disorders With Psychotic Features, Mood Disorders, Psychotic DisordersView official trial listing → -
Terminated NCT NCT00374543
Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
Not yet reported Massachusetts General Hospital 3 participants Est. completion 2008-11 1 siteOther conditions: Generalized Anxiety Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00378183
A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.
Not yet reported Janssen, LP 120 participants Est. completion 2002-05Other conditions: Schizoaffective Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT00391261
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
Not yet reported Cambridge Health Alliance 11 participants Est. completion 2007-10 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar Disorder, Autism Spectrum DisordersView official trial listing → -
Completed NCT NCT00392743
A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
GlaxoSmithKline 60 participants Est. completion 2007-05 7 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00395915
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
Not yet reported Universita di Verona 106 participants Est. completion 2009-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00397033
Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 316 participants Est. completion 2008-02Other conditions: Schizoaffective Disorder, Psychotic DisorderView official trial listing → -
Completed NCT NCT00399334
PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders
Janssen-Cilag, S.A. 1607 participants Est. completion 2005-12Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00399776
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
Creighton University 60 participants Est. completion 2009-09 1 siteOther conditions: Adolescent DepressionView official trial listing → -
Completed NCT NCT00401089
Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
Not yet reported, Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60 participants Est. completion 2007-10 4 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Tardive Dyskinesia, Insulin Resistance, ObesityView official trial listing → -
Completed NCT NCT00406315
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 255 participants Est. completion 2009-03 40 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00412373
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 307 participants Est. completion 2008-06 44 sitesOther conditions: Schizoaffective Disorder, Psychotic DisorderView official trial listing → -
Terminated NCT NCT00418873
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
Not yet reported Astellas Pharma Inc 39 participants Est. completion 2009-12 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00423878
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Not yet reported National Institute of Mental Health (NIMH) 215 participants Est. completion 2010-03 28 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Withdrawn NCT NCT00425815
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
Not yet reported University of California, Los Angeles Est. completion 2009-04 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00431574
Antipsychotic Medication Extended Dosing Study
Not yet reported Centre for Addiction and Mental Health 120 participants Est. completion 2007-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00433121
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
Not yet reported Sykehuset Innlandet HF 24 participants Est. completion 2007-08 1 siteOther conditions: DementiaView official trial listing → -
Completed NCT NCT00451399
Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain
Not yet reported Central South University 128 participants Est. completion 2006-12 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00456976
Efficacy of Selegiline in Negative Symptoms of Schizophrenia
Not yet reported Tabriz University 70 participants Est. completion 2007-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00460512
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia
Not yet reported Janssen-Cilag International NV 1814 participants Est. completion 2020-03-04 231 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00474227
Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness
Not yet reported Lev-Hasharon Mental Healtlh Center 50 participants Est. completion 2007-10 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00495352
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
Not yet reported Yu-Li Hospital 360 participants Est. completion 2008-12 1 siteOther conditions: Tobacco Dependence, SchizophreniaView official trial listing → -
Completed NCT NCT00498550
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Not yet reported Dartmouth-Hitchcock Medical Center 31 participants Est. completion 2009-03 4 sitesOther conditions: Schizophrenia, Dual Diagnosis, Schizoaffective Disorder, Psychotic Disorder, Cannabis AbuseView official trial listing → -
Completed NCT NCT00515723
Glucose and Lipid Metabolism on Antipsychotic Medication
Not yet reported Washington University School of Medicine 96 participants Est. completion 2008-12 2 sitesType 2 diabetes Other conditions: Schizophrenia, Schizoaffective Disorder, HyperglycemiaView official trial listing → -
Completed NCT NCT00523445
The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia
Not yet reported Inje University 120 participants Est. completion 2009-07 5 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00526877
An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
Not yet reported Johnson & Johnson Taiwan Ltd 31 participants Est. completion 2009-01-31 1 siteOther conditions: Schizophrenia, Schizoaffective DisordersView official trial listing → -
Completed NCT NCT00534222
Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect
AstraZeneca 387 participants Est. completion 2007-12 6 sitesOther conditions: Mania, SchizophreniaView official trial listing → -
Completed NCT NCT00535574
Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
Not yet reported Beersheva Mental Health Center 90 participants Est. completion 2011-05 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00536783
Schizophrenia Sensory Gating Deficit With Quetiapine
New Mexico VA Healthcare System 20 participants Est. completion 2006-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00538642
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2011-11 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Status unknown NCT NCT00541554
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Not yet reported Genovate Biotechnology Co., Ltd., Est. completion 2009-02Other conditions: Hyperprolactinemia, Weight Gain, DyslipidemiaView official trial listing → -
Completed NCT NCT00555412
Staccato Loxapine Multidose PK
Not yet reported Alexza Pharmaceuticals, Inc. 40 participants Est. completion 2007-12 1 siteOther conditions: Volunteers on Chronic, Stable Antipsychotic RegimensView official trial listing → -
Completed NCT NCT00556140
The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
Not yet reported Massachusetts General Hospital 16 participants Est. completion 2008-01 1 siteOther conditions: Psychotic DepressionView official trial listing → -
Status unknown NCT NCT00563017
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Not yet reported Hospital Authority, Hong Kong 30 participants Est. completion 2005-11 1 siteOther conditions: Schizophrenia, Catatonic, Schizophrenia, Disorganized, Schizophrenia, Paranoid, Schizophrenia, Psychotic DisordersView official trial listing → -
Status unknown NCT NCT00567099
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Not yet reported New Mexico VA Healthcare System 20 participants Est. completion 2008-09 1 siteOther conditions: Schizophrenia, Sensory GatingView official trial listing → -
Status unknown NCT NCT00569504
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
Seoul National Hospital 1000 participants Est. completion 2009-09 1 siteMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00589914
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1221 participants Est. completion 2009-06 82 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00590577
Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 652 participants Est. completion 2008-03 66 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00594269
Dementia Antipsychotics And Antidepressants Discontinuation Study
Not yet reported Sykehuset Innlandet HF 149 participants Est. completion 2010-12 8 sitesOther conditions: DementiaView official trial listing → -
Completed NCT NCT00617240
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
Not yet reported University of North Carolina, Chapel Hill 9 participants Est. completion 2012-10 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00621998
Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
Not yet reported Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60 participants Est. completion 2004-06 1 siteOther conditions: Neuroleptic-Induced Tardive DyskinesiaView official trial listing → -
Completed NCT NCT00628290
Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
Not yet reported University of Cologne 42 participants Est. completion 2008-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00632645
Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2017-04-28 1 siteOther conditions: Huntington DiseaseView official trial listing → -
Completed NCT NCT00640562
Quetiapine Extended Release Depression Symptoms
Not yet reported AstraZeneca 216 participants Est. completion 2010-02 21 sitesOther conditions: Schizophrenia, DepressionView official trial listing → -
Completed NCT NCT00643123
Allopurinol Add-on Treatment for Refractory Mania
Not yet reported Cedars-Sinai Medical Center 40 participants Est. completion 2010-06 1 siteOther conditions: Bipolar Disorder, Mixed Mania, Treatment-Resistant ManiaView official trial listing → -
Completed NCT NCT00649064
A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 46 participants Est. completion 2004-09 3 sitesOther conditions: Schizoaffective Disorder, SchizophreniaView official trial listing → -
Terminated NCT NCT00649220
Memantine and Antipsychotics Use
Not yet reported Merz Pharmaceuticals GmbH 19 participants Est. completion 2009-06 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00649844
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 147 participants Est. completion 2004-09 22 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00686946
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)
The Alfred 500 participants Est. completion 2025-12 1 siteOther conditions: Pregnancy, Mental DisordersView official trial listing → -
Completed NCT NCT00690274
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
Not yet reported University of Texas Southwestern Medical Center 52 participants Est. completion 2011-10 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00692133
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment
AstraZeneca 250 participants Est. completion 2008-08 32 sitesOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT00692185
Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
Not yet reported New York State Psychiatric Institute 23 participants Est. completion 2010-09 1 siteOther conditions: Eating DisordersView official trial listing → -
Terminated NCT NCT00693472
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2009-01-09Other conditions: Akathisia, Drug-Induced, Antipsychotic Agents, Movement DisordersView official trial listing → -
Completed NCT NCT00696813
Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics
Janssen-Cilag International NV 3064 participants Est. completion 2011-01 84 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00698295
Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication
Seoul National University Hospital 60 participants Est. completion 2010-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00709202
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
Not yet reported Nathan Kline Institute for Psychiatric Research 48 participants Est. completion 2016-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar I Disorder, Bipolar II, Bipolar NOS(Not Otherwise Specified), Psychotic Disorder Not Otherwise Specified, Autism Spectrum DisorderView official trial listing → -
Completed NCT NCT00709345
Behavioral Intervention to Reduce Novel Antipsychotic Medication Health Risks
Not yet reported, Not yet reported Medical College of Wisconsin 333 participants Est. completion 2011-07Other conditions: Mental IllnessView official trial listing → -
Completed NCT NCT00725075
Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)
Not yet reported Merck Sharp & Dohme LLC 215 participants Est. completion 2008-10-24Other conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00750776
KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
Psychiatric Centre Rigshospitalet 212 participants Est. completion 2012-08 10 sitesOther conditions: Antipsychotic Treatment, Quality Assurance, Medical TreatmentView official trial listing → -
Status unknown NCT NCT00752960
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics
Genomas, Inc 1000 participants Est. completion 2009-12 2 sitesOther conditions: PsychosesView official trial listing → -
Completed NCT NCT00761579
Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission
Not yet reported Janssen Korea, Ltd., Korea 190 participants Est. completion 2010-12 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00761605
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants
Not yet reported Janssen Korea, Ltd., Korea 387 participants Est. completion 2010-10 8 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00762814
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease
Not yet reported Washington University School of Medicine 4 participants Est. completion 2009-06 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00763438
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
Not yet reported H. Lundbeck A/S 18 participants Est. completion 2010-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00768326
Efficacy of Lu 31-130 in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 280 participants Est. completion 2009-11 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00770744
Efficacy of Lu 31-130 in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 93 participants Est. completion 2009-11 21 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT00786318
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Not yet reported George Washington University Est. completion 2011-07 1 siteOther conditions: Psychosis, Agitation, DeliriumView official trial listing → -
Status unknown NCT NCT00789022
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
Shalvata Mental Health Center 80 participants 1 siteOther conditions: Schizophrenia, Schizophreniform, Schizoaffective Disorder, Brief Psychotic EpisodeView official trial listing → -
Completed NCT NCT00790517
Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)
Not yet reported Kaiser Permanente 200 participants Est. completion 2014-12 3 sitesType 2 diabetes Other conditions: Weight Loss, Psychotic DisordersView official trial listing → -
Completed NCT NCT00791349
A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141 participants Est. completion 2005-05Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00796029
A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 5 participants Est. completion 2003-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00796640
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35 participants Est. completion 2003-11Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00797927
Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia
Not yet reported National Taiwan University Hospital 30 participants Est. completion 2009-04 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00799383
Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
Not yet reported Chadi A. Calarge 47 participants Est. completion 2014-03 1 siteOther conditions: Risperidone-induced HyperprolactinemiaView official trial listing → -
Completed NCT NCT00809731
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
AstraZeneca 490 participants Est. completion 2010-09 17 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00816907
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
Not yet reported National Institute of Mental Health (NIMH) 146 participants Est. completion 2010-03 16 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT00817323
What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?
Not yet reported University of British Columbia Est. completion 2013-12Other conditions: Bipolar DepressionView official trial listing → -
Status unknown NCT NCT00825045
Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
Not yet reported Centre for Addiction and Mental Health 14 participants Est. completion 2020-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Terminated NCT NCT00833300
Haloperidol vs Olanzapine for the Management of ICU Delirium
Not yet reported Richard Hall 200 participants Est. completion 2011-11 2 sitesOther conditions: Delirium, AgitationView official trial listing → -
Completed NCT NCT00833456
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
AstraZeneca 106 participants Est. completion 2010-11 14 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00833976
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Not yet reported Massachusetts General Hospital 65 participants Est. completion 2013-03 1 siteOther conditions: High Triglycerides, Hypercholesterolemia, Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00842608
Pharmacological Management of Delirium
Not yet reported Indiana University 551 participants Est. completion 2015-07 3 sitesOther conditions: Delirium, Cognitive ImpairmentView official trial listing → -
Completed NCT NCT00857064
Subjective Well Being of Schizophrenic Patients in Greece
AstraZeneca 600 participants Est. completion 2009-10 24 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00862992
Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia
Not yet reported Tanabe Pharma Corporation 34 participants Est. completion 2009-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00885690
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)
Not yet reported University of Aarhus 11 participants Est. completion 2012-11 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00888264
A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
AstraZeneca 152 participants Est. completion 2010-08 45 sitesOther conditions: Bipolar DisordersView official trial listing → -
Completed NCT NCT00888953
Nursing Homes Study of Fall Risk Assessment Oriented to Intervention
Not yet reported Fundacio Salut i Envelliment UAB 331 participants Est. completion 2012-04 1 siteOther conditions: Accidental Falls, Activities of Daily Living, Quality of Life, Self-EfficacyView official trial listing → -
Completed NCT NCT00892489
A Bioequivalence Study of 15 mg ER OROS Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 2004-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00895921
Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
Not yet reported Veterans Medical Research Foundation 30 participants Est. completion 2010-06 1 siteOther conditions: DiabetesView official trial listing → -
Withdrawn NCT NCT00910780
Metabolic Effects of Antipsychotic Substitution in Children
Not yet reported, Not yet reported Washington University School of Medicine Est. completion 2009-11Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00910988
Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
Not yet reported Washington University School of Medicine 46 participants Est. completion 2012-06 1 siteOther conditions: Hyperglycemia, HyperlipidemiaView official trial listing → -
Completed NCT NCT00922272
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
Not yet reported Shire 92 participants Est. completion 2011-01-20 27 sitesOther conditions: Schizophrenia and Predominant Negative SymptomsView official trial listing → -
Terminated NCT NCT00931996
Oculomotor and Spatial Cognition Deficits in Schizophrenia
Not yet reported University of Illinois at Chicago 12 participants Est. completion 2011-11 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00937716
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
University of Alabama at Birmingham 75 participants Est. completion 2021-06-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00937755
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
Taipei Medical University Hospital 80 participants Est. completion 2009-05 1 siteOther conditions: Schizophrenia, AntipsychoticsView official trial listing → -
Completed NCT NCT00946491
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Not yet reported Sandoz 30 participants Est. completion 1987-05Other conditions: PsychosisView official trial listing → -
Completed NCT NCT00952757
Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine
Investigaciones Médicas Montejo S.L. 35 participants Est. completion 2008-08 6 sitesOther conditions: APS-related Hyperprolactinaemia, Schizophrenia, Bipolar DisorderView official trial listing → -
Terminated NCT NCT00954603
A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium
Not yet reported Chiang Mai University 52 participants Est. completion 2012-07 1 siteOther conditions: DeliriumView official trial listing → -
Terminated NCT NCT00977522
A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia
Not yet reported Pfizer 207 participants Est. completion 2010-09 37 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00981526
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Not yet reported University of Massachusetts, Worcester 66 participants Est. completion 2012-05 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00999895
A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients
AstraZeneca 574 participants Est. completion 2010-09 43 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01004354
Vitamin D Supplementation in Psychiatric Illnesses
Not yet reported University of Massachusetts, Worcester 12 participants Est. completion 2010-06 1 siteOther conditions: Obesity, Vitamin D Deficiency, Psychosis, Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01029769
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
Not yet reported Technical University of Munich 350 participants Est. completion 2015-03 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT01043250
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
Samsung Medical Center 81 participants Est. completion 2010-12 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01050582
A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244 participants Est. completion 2011-07 28 sites Stand-aloneOther conditions: Schizophrenia, Bipolar Disorder, Autistic Disorder, Conduct and Other Disruptive Behavior DisordersView official trial listing → -
Completed NCT NCT01052714
Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2
Not yet reported VA Office of Research and Development 121 participants Est. completion 2015-05-28 3 sitesOther conditions: Diabetes, Obesity, Weight GainView official trial listing → -
Status unknown NCT NCT01057849
Standard Comprehensive Intervention to Treat First-episode Schizophrenia
Not yet reported Peking University 600 participants 6 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01066403
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia
Not yet reported Heidelberg University 28 participants Est. completion 2008-03 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01075295
Prevention of Weight Gain in Early Psychoses
Not yet reported Centre for Addiction and Mental Health 70 participants Est. completion 2012-12 1 siteOther conditions: Schizophreniform Disorder, Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder, Substance-Induced Psychoses, Psychosis Not Otherwise Specified, Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01081769
Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
Not yet reported Janssen-Cilag International NV 769 participants Est. completion 2013-02 94 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01082588
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
Not yet reported Massachusetts General Hospital 60 participants Est. completion 2012-09 1 siteOther conditions: Schizophrenia, Schizoaffective Disorders, Schizophreniform DisordersView official trial listing → -
Completed NCT NCT01104779
Safety and Efficacy of Cariprazine in Schizophrenia
Not yet reported Forest Laboratories 446 participants Est. completion 2011-12-15 41 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01104792
Long-term Study of Cariprazine in Patients With Schizophrenia
Not yet reported Forest Laboratories 752 participants Est. completion 2013-01-31 86 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01116830
A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder
Not yet reported Hoffmann-La Roche 29 participants Est. completion 2014-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01119014
Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis
Not yet reported Anne Katrine Pagsberg 300 participants Est. completion 2015-07 9 sitesOther conditions: PsychosisView official trial listing → -
Completed NCT NCT01125267
Promoting Adherence to Treatment in Schizophrenia
Not yet reported University of California, Los Angeles 174 participants Est. completion 2008-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01129674
A Long-Term, Open-Label, Study on Schizophrenia
Not yet reported, Not yet reported Denovo Biopharma LLC 560 participants Est. completion 2012-10 81 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01143077
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Not yet reported Sumitomo Pharma America, Inc. 244 participants Est. completion 2011-05 27 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01154829
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
Not yet reported University of Copenhagen 136 participants Est. completion 2016-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01157351
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
Not yet reported Janssen Scientific Affairs, LLC 450 participants Est. completion 2013-12 56 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01177709
Metformin for Weight Loss in Schizophrenia
Not yet reported Nathan Kline Institute for Psychiatric Research 12 participants Est. completion 2011-04 1 siteOther conditions: Schizophrenia, ObesityView official trial listing → -
Completed NCT NCT01181960
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Janssen Scientific Affairs, LLC 1066 participants Est. completion 2013-11 34 sitesOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT01184235
Multidimensional Measurement of Psychopharmacological Treatment Response
Child Psychopharmacology Institute 44 participants Est. completion 2011-08 1 siteOther conditions: Autism Spectrum Disorders, Mood Disorders, Sleep Disorders, Attention Deficit DisordersView official trial listing → -
Completed NCT NCT01192867
A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)
Not yet reported Hoffmann-La Roche 629 participants Est. completion 2014-05-26 122 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01192880
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia
Not yet reported Hoffmann-La Roche 625 participants Est. completion 2014-07 103 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01206153
Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients
Not yet reported Central South University 84 participants Est. completion 2010-03 1 siteOther conditions: AmenorrheaView official trial listing → -
Completed NCT NCT01211522
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
Not yet reported Vanderbilt University Medical Center 566 participants Est. completion 2018-07-19 16 sitesOther conditions: Delirium, Impaired Cognition, Long Term Psychologic DisordersView official trial listing → -
Completed NCT NCT01214135
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia
AstraZeneca 300 participants Est. completion 2010-12 14 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01222793
Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia
National Institute on Drug Abuse (NIDA) 60 participants Est. completion 2012-05-03 1 siteOther conditions: Schizophrenia, ObesityView official trial listing → -
Withdrawn NCT NCT01234298
SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia
Not yet reported Shire Est. completion 2014-02-24Other conditions: Negative Symptoms of SchizophreniaView official trial listing → -
Completed NCT NCT01234454
Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI
Not yet reported University of North Carolina, Chapel Hill 34 participants Est. completion 2007-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01235520
A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)
Not yet reported Hoffmann-La Roche 595 participants Est. completion 2014-07 121 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01235559
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)
Not yet reported Hoffmann-La Roche 604 participants Est. completion 2015-03 90 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01235585
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)
Not yet reported Hoffmann-La Roche 597 participants Est. completion 2014-09 120 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01245348
Relative Effectiveness of Schizophrenia Therapy Study
Medco Health Solutions, Inc. 1110 participants Est. completion 2012-12 1 siteOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT01246232
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
Not yet reported Imperial College London 69 participants Est. completion 2015-03 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01269710
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
University of North Carolina, Chapel Hill 4 participants Est. completion 2011-03 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorder, Not Otherwise Specified, Prodromal Schizophrenia, Mood Disorder, Bipolar Disorder, Major Depressive Disorder, Depressive Disorder, Not Otherwise Specified, Mood Disorder, Not Otherwise Specified, Autism Spectrum DisorderView official trial listing → -
Status unknown NCT NCT01280305
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
Not yet reported Sheba Medical Center 200 participants Est. completion 2013-03 13 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01280396
Metabolic Side-effects for Second-generation Antipsychotics
The University of Hong Kong 241 participants Est. completion 2014-12 1 siteOther conditions: Mental DisordersView official trial listing → -
Completed NCT NCT01281527
Paliperidone Palmitate Flexible Dosing in Schizophrenia
Not yet reported Janssen-Cilag International NV 1044 participants Est. completion 2013-11 127 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01284959
Different Safety Profile of Risperidone and Paliperidone Extended-release
Not yet reported Chonbuk National University Hospital 34 participants Est. completion 2010-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01291368
Sedation Influence on Delirium and Post-traumatic Stress-disorder as a Result of Hospitalization in Intensive Care
University of Aarhus 248 participants Est. completion 2012-02 2 sitesOther conditions: Delirium, Stress Disorders, Post-TraumaticView official trial listing → -
Completed NCT NCT01295372
Safety and Efficacy of Zicronapine in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 160 participants 24 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01320982
Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Sheba Medical Center 400 participants Est. completion 2012-07 14 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01377233
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 46 participants 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01384279
The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity
Not yet reported Beitou Armed Forces Hospital, Taipei, Taiwan 25 participants Est. completion 2012-01 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT01409590
Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications
Not yet reported Sheba Medical Center 100 participants Est. completion 2009-08 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01421342
VA Augmentation and Switching Treatments for Improving Depression Outcomes
Not yet reported VA Office of Research and Development 1522 participants Est. completion 2016-06 35 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01446328
Bergen Psychosis Project 2 - The Best Intro Study
Not yet reported Haukeland University Hospital 151 participants Est. completion 2017-12 4 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT01447082
General Practice Research Database Seroquel XR Safety Study
AstraZeneca 37372 participants Est. completion 2012-12 1 siteOther conditions: Schizophrenia, Major Depressive Disorder, Bipolar DisorderView official trial listing → -
Terminated NCT NCT01454453
Optimisation of Antipsychotic Drug Use in Older People
Not yet reported Institute of Psychiatry, London 64 participants Est. completion 2015-07 1 siteOther conditions: Alzheimer's Disease, SchizophreniaView official trial listing → -
Completed NCT NCT01479413
Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs
Chang Gung Memorial Hospital 77 participants Est. completion 2013-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01495169
Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
Not yet reported Vanda Pharmaceuticals 33 participants Est. completion 2015-02 10 sitesOther conditions: Safety and Tolerability of IloperidoneView official trial listing → -
Completed NCT NCT01516424
Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
Not yet reported Marubeni Pharmaceuticals (Suzhou) Co., Ltd. 267 participants Est. completion 2013-02 16 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01527448
Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II
Not yet reported BC Women's Hospital & Health Centre 26 participants Est. completion 2010-07 1 siteOther conditions: Postpartum DepressionView official trial listing → -
Completed NCT NCT01530308
Haloperidol Prophylaxis in Older Emergency Department Patients
Not yet reported Amsterdam UMC, location VUmc 242 participants Est. completion 2015-10 6 sitesOther conditions: DeliriumView official trial listing → -
Completed NCT NCT01543321
Xenazine in Late Dyskinetic Syndrome With Neuroleptics
Not yet reported Centre Hospitalier Universitaire, Amiens 54 participants Est. completion 2017-08 19 sitesOther conditions: Tardive DyskinesiaView official trial listing → -
Completed NCT NCT01544608
Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
AstraZeneca 1076 participants Est. completion 2012-12 7 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01552772
Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 60 participants Est. completion 2012-04 12 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT01567124
Alleviating the Metabolic Side Effects of Antipsychotic Medications
Not yet reported Baker Heart and Diabetes Institute 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01578486
Salsalate as an Adjunctive Treatment for Patients With Schizophrenia
Not yet reported University of Massachusetts, Worcester 17 participants Est. completion 2015-07 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Terminated NCT NCT01621737
Antipsychotic Effects of Oxytocin
Not yet reported University of California, San Diego 42 participants Est. completion 2018-12 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01625897
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 125 participants Est. completion 2015-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01626859
A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 38 participants Est. completion 2013-08 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01626885
A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 42 participants Est. completion 2014-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01636037
Antipsychotic Augmentation With L-Dopa
Not yet reported Centre for Addiction and Mental Health 13 participants Est. completion 2016-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01646827
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 37 participants Est. completion 2013-04 6 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01662648
Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia
Not yet reported Janssen Pharmaceutica 1117 participants Est. completion 2009-04Other conditions: SchizophreniaView official trial listing → -
Suspended NCT NCT01684657
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Not yet reported University of California, Irvine 32 participants Est. completion 2014-05 1 siteOther conditions: StutteringView official trial listing → -
Completed NCT NCT01689389
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
AstraZeneca 2292 participants Est. completion 2014-12 19 sitesOther conditions: Schizophrenia, Bipolar EpisodesView official trial listing → -
Completed NCT NCT01714661
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Not yet reported FORUM Pharmaceuticals Inc 753 participants Est. completion 2015-12 94 sitesOther conditions: Schizophrenia, Impaired CognitionView official trial listing → -
Completed NCT NCT01714713
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Not yet reported FORUM Pharmaceuticals Inc 830 participants Est. completion 2015-10 128 sitesOther conditions: Schizophrenia, Impaired CognitionView official trial listing → -
Completed NCT NCT01724359
Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia
Not yet reported Janssen-Cilag, S.A. 95 participants Est. completion 2009-11 5 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT01724372
The Role of Antidepressants or Antipsychotics in Preventing Psychosis
Not yet reported St. Luke's-Roosevelt Hospital Center Est. completion 2014-05Other conditions: Psychotic DisorderView official trial listing → -
Completed NCT NCT01739127
Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
University of British Columbia 83 participants Est. completion 2016-02 1 siteMetabolic syndrome Other conditions: Psychotic Disorders, Bipolar DisorderView official trial listing → -
Withdrawn NCT NCT01758887
Antipsychotic Discontinuation in High-risk Subjects
Seoul National University Hospital Est. completion 2016-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01779700
Fingolimod in Schizophrenia Patients
Not yet reported Indiana University 40 participants Est. completion 2016-08 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01794429
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
Not yet reported Bjorn H. Ebdrup 45 participants Est. completion 2015-06 1 siteMetabolic syndrome Other conditions: Obesity, Drug-induced Obesity, SchizophreniaView official trial listing → -
Completed NCT NCT01797575
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
Not yet reported The University of Texas Health Science Center, Houston 38 participants Est. completion 2017-02-01 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT01811160
Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics
Not yet reported Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50 participants Est. completion 2011-11 1 siteOther conditions: Second Generation Antipsychotic Induced Metabolic Adverse EffectsView official trial listing → -
Completed NCT NCT01811459
Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium
Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 107 participants Est. completion 2016-09 1 siteOther conditions: DeliriumView official trial listing → -
Status unknown NCT NCT01831986
Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders
Not yet reported Sha'ar Menashe Mental Health Center 60 participants Est. completion 2013-12Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01852331
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
Not yet reported The University of Hong Kong 103 participants Est. completion 2014-11 4 sitesOther conditions: Schizophrenia, Schizophrenic Disorder, Hyperprolactinemia, HyperprolactinaemiaView official trial listing → -
Completed NCT NCT01858948
SGA-induced Metabolic Syndrome in Bipolar Youth
Not yet reported University of Cincinnati 19 participants Est. completion 2018-04 1 siteOther conditions: Bipolar Youth Treated With Second-generation AntipsychoticsView official trial listing → -
Completed NCT NCT01871974
Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
Not yet reported Astellas Pharma Inc 16 participants Est. completion 2010-03 2 sitesOther conditions: Major Depressive Disorder PatientsView official trial listing → -
Completed NCT NCT01871987
Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers
Not yet reported Astellas Pharma Inc 24 participants Est. completion 2009-08 1 siteOther conditions: Healthy, Plasma Concentration Change of QuetiapineView official trial listing → -
Completed NCT NCT01888107
Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Janssen-Cilag S.p.A. 347 participants Est. completion 2007-04Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Terminated NCT NCT01894984
An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 640 participants Est. completion 2009-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01903200
Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder
Not yet reported Astellas Pharma Inc 16 participants Est. completion 2011-09 2 sitesOther conditions: Major Depressive Disorder PatientsView official trial listing → -
Completed NCT NCT01908296
Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers
Not yet reported Astellas Pharma Inc 24 participants Est. completion 2011-08 1 siteOther conditions: Healthy, Pharmacokinetics of QuetiapineView official trial listing → -
Terminated NCT NCT01913327
Antipsychotic Effects on Brain Function in Schizophrenia
Not yet reported University of California, San Francisco 4 participants Est. completion 2017-01 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT01920802
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
Not yet reported New York State Psychiatric Institute 31 participants Est. completion 2014-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01924520
Oral Multiple-dose Study in Patients With Major Depressive Disorder
Not yet reported Astellas Pharma Inc 32 participants Est. completion 2011-05 2 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT01936220
Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 200 participants Est. completion 2016-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01938859
Algorithm Guided Treatment Strategies for Bipolar Depression
Not yet reported Shanghai Mental Health Center 360 participants Est. completion 2018-12 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT01947803
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
Not yet reported Xian-Janssen Pharmaceutical Ltd. 353 participants Est. completion 2015-03 12 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01976793
Retrospective Observational Study DIANA Study
AstraZeneca 450 participants Est. completion 2013-12 8 sitesOther conditions: Major Depressive EpisodeView official trial listing → -
Completed NCT NCT01977300
Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
Not yet reported University of British Columbia 159 participants Est. completion 2011-08 1 siteOther conditions: Bipolar I DisorderView official trial listing → -
Completed NCT NCT01990755
Neurobiology of Eating Disorders Treatments
Not yet reported University of Turin, Italy 112 participants Est. completion 2013-05 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT01994109
Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects
Not yet reported Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187 participants Est. completion 2017-01 34 sitesOther conditions: SialorrheaView official trial listing → -
Completed NCT NCT01999309
Simvastatin Addition for Patients With Recent-onset Schizophrenia
Not yet reported Iris Sommer 121 participants Est. completion 2019-12-19 2 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOSView official trial listing → -
Completed NCT NCT02009371
A Clinical Study of Light Therapy on Depressive Episodes of Bipolar Disorder
Not yet reported Peking University 80 participants Est. completion 2015-07 1 siteOther conditions: Depressive Episodes of Bipolar DisorderView official trial listing → -
Completed NCT NCT02013609
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 48 participants Est. completion 2014-10 24 sitesOther conditions: MDDView official trial listing → -
Completed NCT NCT02013622
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 49 participants Est. completion 2014-10 22 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02019329
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
Not yet reported Hoffmann-La Roche 32 participants Est. completion 2014-08 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT02020356
Music Therapy in Alzheimer's Disease
Not yet reported University Hospital, Toulouse 35 participants Est. completion 2015-06 7 sitesOther conditions: Alzheimer's Type DementiaView official trial listing → -
Completed NCT NCT02029989
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Not yet reported University of Minnesota 121 participants Est. completion 2012-02 1 siteOther conditions: Hyperlipidemia, Diabetes, HypertensionView official trial listing → -
Completed NCT NCT02037074
Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics
Not yet reported FORUM Pharmaceuticals Inc 40 participants 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02051387
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
Not yet reported Central Institute of Mental Health, Mannheim 74 participants Est. completion 2017-08 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02054702
Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 97 participants Est. completion 2014-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02085447
A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness
Not yet reported University Hospitals Cleveland Medical Center 30 participants Est. completion 2016-12 1 siteOther conditions: Psychotic Disorders, Schizophrenia, Schizoaffective Disorder, Medication Adherence, Medication Non-AdherenceView official trial listing → -
Completed NCT NCT02087579
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Not yet reported Janssen Research & Development, LLC 305 participants Est. completion 2014-12 24 sitesOther conditions: Psychotic Disorders, Schizophrenia, Bipolar Disorder, Depressive DisorderView official trial listing → -
Completed NCT NCT02109939
Genomics Used to Improve DEpression Decisions
Not yet reported Assurex Health Inc. 1398 participants Est. completion 2017-07-31 61 sitesOther conditions: Major Depressive Disorder (MDD)View official trial listing → -
Completed NCT NCT02137278
Stop Vasodepressor Drugs in Reflex Syncope
Not yet reported Gruppo Italiano Multidisciplinare per lo Studio della Sincope 58 participants Est. completion 2015-12 1 siteOther conditions: Hypotensive SyncopeView official trial listing → -
Completed NCT NCT02142556
The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics
Not yet reported Tri-Service General Hospital (TSGH) 61 participants Est. completion 2012-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02181803
Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003)
Not yet reported Merck Sharp & Dohme LLC 55 participants Est. completion 2015-04-23Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02184767
Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 30 participants Est. completion 2015-05 2 sitesOther conditions: BiPolarView official trial listing → -
Completed NCT NCT02192723
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
Not yet reported Beijing HuiLongGuan Hospital 550 participants Est. completion 2014-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02194933
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 38 participants Est. completion 2016-04 1 siteOther conditions: Schizophrenia With ImpulsivityView official trial listing → -
Completed NCT NCT02220504
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
Not yet reported Fundación Marques de Valdecilla 68 participants Est. completion 2014-07 1 siteOther conditions: Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Completed NCT NCT02281773
A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.
Not yet reported Boehringer Ingelheim 518 participants Est. completion 2016-06-13 43 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02282761
A Trial to Assess the Antipsychotic Efficacy of ITI-007
Not yet reported Intra-Cellular Therapies, Inc. 450 participants Est. completion 2015-09 11 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02298985
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Not yet reported Beersheva Mental Health Center 38 participants Est. completion 2017-05 2 sitesOther conditions: Chronic SchizophreniaView official trial listing → -
Status unknown NCT NCT02334904
Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
University of British Columbia 60 participants Est. completion 2016-06 1 siteOther conditions: First-Episode Psychosis, Bipolar DisorderView official trial listing → -
Terminated NCT NCT02357849
Fluoxetine vs Aripiprazole Comparative Trial (FACT)
Not yet reported Northwell Health 9 participants Est. completion 2022-04-04 1 siteOther conditions: Attenuated Psychosis SyndromeView official trial listing → -
Status unknown NCT NCT02361255
Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism
Corporal Michael J. Crescenz VA Medical Center 40 participants Est. completion 2019-04 1 siteOther conditions: Secondary Parkinsonism, Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02409823
Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
Pontifical Catholic University of Argentina 665 participants Est. completion 2015-08Other conditions: Schizophrenia, Major Depressive Disorder, Bipolar Depressive Disorder, Parkinson's Disease With HallucinationsView official trial listing → -
Status unknown NCT NCT02423096
Neuroendocrine and Metabolite Substrates in Schizophrenia
Chang Gung Memorial Hospital 200 participants Est. completion 2016-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02431702
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Not yet reported Janssen Scientific Affairs, LLC 337 participants Est. completion 2019-11-12 38 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Terminated NCT NCT02435095
Antipsychotic Induced Structural and Functional Brain Changes
Not yet reported RWTH Aachen University 174 participants Est. completion 2020-08 11 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02440594
The PACE/PACENET Behavioral Health Laboratory Project
Not yet reported University of Pennsylvania 2432 participants Est. completion 2015-06 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT02466477
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
Not yet reported Assurex Health Inc. 542 participants Est. completion 2019-09 14 sitesOther conditions: Depressive Disorder, Major, Depression, Depressive DisorderView official trial listing → -
Completed NCT NCT02469155
A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
Not yet reported Intra-Cellular Therapies, Inc. 696 participants Est. completion 2016-08 11 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02496650
Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal State in the ICU
Not yet reported Bogomolets National Medical University 70 participants Est. completion 2015-06Other conditions: Alcohol Withdrawal StateView official trial listing → -
Completed NCT NCT02500628
Heart Rate Variability in Response to Metformin Challenge
Not yet reported Woodinville Psychiatric Associates 61 participants Est. completion 2016-02 1 siteType 2 diabetes Other conditions: Fibromyalgia, Mitochondrial Diseases, Movement DisordersView official trial listing → -
Completed NCT NCT02515773
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
Not yet reported Melissa Delbello 1565 participants Est. completion 2023-06 29 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT02536846
The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals
Not yet reported Dost Ongur 35 participants Est. completion 2019-11-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02573168
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics
Not yet reported St. Joseph's Healthcare Hamilton 103 participants Est. completion 2020-09 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02573701
Guideline vs Usual Treatment in Schizophrenic Adolescents
Not yet reported Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico 91 participants Est. completion 2015-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02582736
Antipsychotics and Risk of Hyperglycemic Emergencies
Canadian Network for Observational Drug Effect Studies, CNODES 725489 participants Est. completion 2012-12 1 siteType 2 diabetes Other conditions: Psychotic Disorders, Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT02593734
Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
Not yet reported University of Ghana Medical School 139 participants Est. completion 2015-07 1 siteOther conditions: Schizophrenia, Mood Disorders,, Anxiety DisorderView official trial listing → -
Completed NCT NCT02604056
Pragmatic Cluster Trial for Nursing Home Antipsychotic Prescribing
Not yet reported Women's College Hospital 60 participants Est. completion 2017-04Other conditions: Adverse Effect of Other Antipsychotics and NeurolepticsView official trial listing → -
Completed NCT NCT02634346
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
Not yet reported Alkermes, Inc. 403 participants Est. completion 2017-06-07 31 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02634463
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
Not yet reported Janssen Research & Development, LLC 81 participants Est. completion 2016-11-09 1 siteOther conditions: Immunoassay, AntipsychoticView official trial listing → -
Completed NCT NCT02640300
Switching Antipsychotics: Abrupt Discontinuation Versus Overlap
Not yet reported Centre for Addiction and Mental Health 33 participants Est. completion 2004-07 1 site Stand-aloneOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02644577
Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
Not yet reported China Medical University, China 110 participants Est. completion 2015-09 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT02697045
Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
Not yet reported Abdi İbrahim Otsuka 23 participants Est. completion 2018-03-31 15 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT02717130
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
Not yet reported Florida Atlantic University 9 participants Est. completion 2017-05-25 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02744313
MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use
Centre for Addiction and Mental Health 17 participants Est. completion 2018-04 1 siteOther conditions: AdiposityView official trial listing → -
Completed NCT NCT02787135
Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis
Not yet reported Philipps University Marburg 94 participants Est. completion 2019-12-31 2 sitesOther conditions: Schizophrenia, Psychotic Disorders, Delusions, Emotions, Self-esteem, SleepView official trial listing → -
Terminated NCT NCT02820519
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
Not yet reported University of Witten/Herdecke 4 participants Est. completion 2017-05-04 1 siteOther conditions: Neuropathic PainView official trial listing → -
Status unknown NCT NCT02880995
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
Not yet reported Seoul National University Hospital 62 participants Est. completion 2019-12 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02897167
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
Fundación Marques de Valdecilla 150 participants Est. completion 2019-03 1 siteOther conditions: Schizophrenia, Mental Disorders, Psychotic DisordersView official trial listing → -
Status unknown NCT NCT02906501
Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances
Shalvata Mental Health Center 45 participants Est. completion 2018-03 1 siteOther conditions: ADHDView official trial listing → -
Completed NCT NCT02909491
Ionized Calcium and Behavioural Disorders in Older Adults (CALICO Study)
University Hospital, Angers 90 participants Est. completion 2017-04-27 1 siteOther conditions: Geriatric DisordersView official trial listing → -
Completed NCT NCT02918370
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
Not yet reported University of Texas Southwestern Medical Center 75 participants Est. completion 2023-06-30 1 siteOther conditions: Bipolar Disorder, Alcoholism, Alcohol AbuseView official trial listing → -
Completed NCT NCT02928965
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
Not yet reported University of Manchester 207 participants Est. completion 2016-05Other conditions: Schizophrenia and Disorders With Psychotic FeaturesView official trial listing → -
Completed NCT NCT02949752
Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
Not yet reported Institute of Mental Health, Singapore 67 participants Est. completion 2020-01-01 1 siteOther conditions: Antipsychotics Weight GainView official trial listing → -
Completed NCT NCT02958800
Deprescribing Antipsychotics in Long-Term Care
Not yet reported McMaster University 6 participants Est. completion 2019-08 1 siteOther conditions: Dementia, BehaviorView official trial listing → -
Completed NCT NCT02970292
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)
Not yet reported ACADIA Pharmaceuticals Inc. 396 participants Est. completion 2019-06-25 105 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02970305
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)
Not yet reported ACADIA Pharmaceuticals Inc. 403 participants Est. completion 2019-10-28 101 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT02986490
Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs
Not yet reported University Hospital, Montpellier 100 participants Est. completion 2017-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT03019887
Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction
Not yet reported Juntendo University 139 participants Est. completion 2017-01Other conditions: Schizophrenia RelapseView official trial listing → -
Completed NCT NCT03116100
Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey
Centre Hospitalier Universitaire, Amiens 30 participants Est. completion 2017-10-15 1 siteOther conditions: Behavior Disorders, NeurolepticView official trial listing → -
Status unknown NCT NCT03130465
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia
Otsuka Pharmaceutical Europe Ltd 636 participants Est. completion 2020-01-31 67 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03130478
Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain
Otsuka Pharmaceutical Europe Ltd 119 participants Est. completion 2018-07-30 15 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03147521
Accidental Falls Care Bundle
Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 10000 participants Est. completion 2017-01-31Other conditions: Accidental FallsView official trial listing → -
Status unknown NCT NCT03155685
Use of Antipsychotics in Palliative Care (NEUROPAL)
University Hospital, Caen 100 participants Est. completion 2018-05Other conditions: Antipsychotics in Palliative CareView official trial listing → -
Status unknown NCT NCT03248180
Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States
National Taiwan University Hospital 160 participants Est. completion 2020-12-31 1 siteOther conditions: Psychosis, RemissionView official trial listing → -
Status unknown NCT NCT03284294
Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia
Not yet reported Universitas Padjadjaran 40 participants Est. completion 2020-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03388554
The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia
Not yet reported Tri-Service General Hospital (TSGH) 60 participants Est. completion 2018-03-02 1 siteAlcohol use disorder Other conditions: Schizophrenia, Schizoaffective Disorder, Neurocognitive Dysfunction, Autonomic Imbalance, Psychosocial Impairment, Quality of LifeView official trial listing → -
Completed NCT NCT03427892
Brexpiprazole for Bipolar Depression
Not yet reported University of Texas Southwestern Medical Center 21 participants Est. completion 2018-03-15 1 siteOther conditions: Bipolar DepressionView official trial listing → -
Completed NCT NCT03430596
a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics
Not yet reported Shanghai Mental Health Center 50 participants Est. completion 2021-12-30 1 siteOther conditions: Extrapyramidal SyndromeView official trial listing → -
Status unknown NCT NCT03434210
The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia
Not yet reported Yi Li MD, PhD 110 participants Est. completion 2020-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Active, not recruiting NCT NCT03442101
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
University of Alabama at Birmingham 156 participants Est. completion 2026-12-31 1 siteOther conditions: PsychosisView official trial listing → -
Status unknown NCT NCT03481465
Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis
Fundación Marques de Valdecilla 200 participants Est. completion 2020-12 1 siteMetabolic syndrome Other conditions: Schizophrenia, PsychosisView official trial listing → -
Completed NCT NCT03510325
Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)
Not yet reported Shanghai Mental Health Center 762 participants Est. completion 2023-09-27 7 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03526354
Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder
Not yet reported University of Massachusetts, Worcester 50 participants Est. completion 2024-02-29 4 sitesSubstance use disorder Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT03537040
Piloting MOL Intervention for Neuroleptic Decision Making
Not yet reported University of Manchester 5 participants Est. completion 2019-05-10 2 sitesOther conditions: Psychosis, Medication AdherenceView official trial listing → -
Terminated NCT NCT03537547
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
Not yet reported Washington University School of Medicine 6 participants Est. completion 2019-08-19 1 siteOther conditions: Major Depressive Disorder, Depression, Depressive Disorder, Depressive Episode, Depression, UnipolarView official trial listing → -
Completed NCT NCT03557593
Optimizing Prescribing of Antipsychotics in Long-Term Care
Not yet reported Queen's University Est. completion 2017-12Other conditions: DementiaView official trial listing → -
Completed NCT NCT03559426
Research Into Antipsychotic Discontinuation and Reduction Trial
Not yet reported University College, London 253 participants Est. completion 2022-03-10 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Delusional Disorder, Schizophreniform DisordersView official trial listing → -
Completed NCT NCT03565068
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)
Not yet reported Merck Sharp & Dohme LLC 75 participants Est. completion 2020-04-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03568500
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 44 participants Est. completion 2019-09-06 5 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, First Episode PsychosisView official trial listing → -
Terminated NCT NCT03628391
Haloperidol for Delirium in Adult Critically Ill Patients
Not yet reported Erasmus Medical Center 142 participants Est. completion 2021-01-23 8 sitesOther conditions: Delirium, Critical Illness, Intensive Care Psychosis, Cognitive Impairment, Cognitive DeclineView official trial listing → -
Completed NCT NCT03629951
A Study for Schizophrenia Relapse Prediction
Janssen Research & Development, LLC 333 participants Est. completion 2021-12-31 10 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03651674
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
Not yet reported Xidian University 200 participants Est. completion 2020-04-01Other conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT03663465
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics
Not yet reported Calo Psychiatric Center 135 participants Est. completion 2014-07-31Other conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03675750
Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism
Shanghai Mental Health Center 120 participants Est. completion 2020-10-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03693794
A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 270 participants Est. completion 2020-12-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03708614
A Study Looking at How Well Children With Autism Spectrum Disorder on Medications Like Having More Protein
Not yet reported Holland Bloorview Kids Rehabilitation Hospital 10 participants Est. completion 2020-06 1 siteOther conditions: Autism Spectrum DisorderView official trial listing → -
Completed NCT NCT03749629
Comparative Effectiveness of Pharmacogenomics for Treatment of Depression
Not yet reported Massachusetts General Hospital 201 participants Est. completion 2022-03-15 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT03788759
Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia
Not yet reported, Not yet reported Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara 48 participants Est. completion 2021-12-01 1 siteOther conditions: Schizophrenia, Oxidative StressView official trial listing → -
Completed NCT NCT03818256
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
Not yet reported Corcept Therapeutics 71 participants Est. completion 2022-07-06 27 sitesOther conditions: Antipsychotic-induced Weight Gain (AIWG)View official trial listing → -
Terminated NCT NCT03852706
EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED)
Not yet reported University of Dublin, Trinity College 4 participants Est. completion 2022-03-25 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03863691
Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.
Not yet reported Philipps University Marburg 85 participants Est. completion 2020-07-15 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT03955549
Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial
Not yet reported Agiad Psychiatry Hospital 99 participants Est. completion 2021-01-30 1 siteOther conditions: Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Completed NCT NCT04002258
Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment
Shanghai Mental Health Center 10363 participants Est. completion 2022-10-25 1 siteOther conditions: Schizophrenia, Antipyretics Toxicity, Prolactin ExcessView official trial listing → -
Completed NCT NCT04002700
A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group
Janssen Research & Development, LLC 1234412 participants Est. completion 2019-05-31 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT04038788
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia
Not yet reported Tri-Service General Hospital (TSGH) 36 participants Est. completion 2019-05-17 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Symptoms, Neurocognitive Dysfunction, Insight Impaired, Quality of Life, Psychosocial Impairment, Autonomic Imbalance, EEG With Abnormally Slow FrequenciesView official trial listing → -
Withdrawn NCT NCT04087109
MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study)
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre Est. completion 2022-01-31 1 siteOther conditions: Polypharmacy, Deprescribing, Adverse Drug EventView official trial listing → -
Status unknown NCT NCT04181346
Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting
Not yet reported Faculdade de Medicina do ABC 82 participants Est. completion 2020-02-28 1 siteOther conditions: NauseaView official trial listing → -
Completed NCT NCT04218981
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
Not yet reported Central South University 200 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Common Mental DisorderView official trial listing → -
Completed NCT NCT04280965
Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury
Not yet reported The University of Texas Health Science Center at San Antonio 28 participants Est. completion 2022-10-17 1 siteOther conditions: Post Traumatic Stress DisorderView official trial listing → -
Completed NCT NCT04317807
R33: Levetiracetam in Early Psychosis
Not yet reported NYU Langone Health 65 participants Est. completion 2025-04-10 1 siteOther conditions: Early PsychosisView official trial listing → -
Completed NCT NCT04373590
Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis
Not yet reported Temple University 18 participants Est. completion 2020-08-30 1 siteOther conditions: Early PsychosisView official trial listing → -
Completed NCT NCT04461119
Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
Not yet reported Newron Pharmaceuticals SPA 138 participants Est. completion 2021-03-13 14 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT04528095
SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
Not yet reported Shanghai Mental Health Center 162 participants Est. completion 2022-12 1 siteOther conditions: Treatment-resistant SchizophreniaView official trial listing → -
Status unknown NCT NCT04529226
Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 75 participants Est. completion 2025-12-30 20 sitesOther conditions: Psychosis, Intellectual DisabilityView official trial listing → -
Status unknown NCT NCT04575103
Monitoring of Arrhythmias in Patients Treated With Antipsychotics
Not yet reported Herlev and Gentofte Hospital 600 participants Est. completion 2024-12-31 18 sitesSubstance use disorder Other conditions: Arrythmia, Antipsychotics and Neuroleptics ToxicityView official trial listing → -
Status unknown NCT NCT04700930
CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia
Not yet reported Psychiatric Hospital of the University of Basel 31 participants Est. completion 2021-10-31 1 siteOther conditions: Schizophrenia and Other Psychotic Disorders, Harm ReductionView official trial listing → -
Status unknown NCT NCT04807634
Role of Intravenous Lipid Emulsion in Improving Coma of Acute Antipsychotics Poisoning
Not yet reported Ain Shams University 30 participants Est. completion 2021-09 1 siteOther conditions: ComaView official trial listing → -
Completed NCT NCT04851691
An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions
Not yet reported University of California, Los Angeles 158 participants Est. completion 2023-08-14 1 siteOther conditions: Alzheimer Disease, Dementia Alzheimers, Dementia of Alzheimer TypeView official trial listing → -
Completed NCT NCT04856124
Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine
Psych Atlanta 10 participants Est. completion 2021-03-01 1 siteOther conditions: Treatment Resistant DepressionView official trial listing → -
Status unknown NCT NCT04895488
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
Not yet reported, Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 37 participants Est. completion 2025-12-20 1 siteOther conditions: Cognitive Impairment With Primary Psychotic Disorder, Negative Symptoms With Primary Psychotic DisorderView official trial listing → -
Completed NCT NCT04898270
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
Not yet reported Taichung Veterans General Hospital 30 participants Est. completion 2021-04-20 1 siteMetabolic syndrome Other conditions: Schizophrenia; Psychosis, Flupentixol, Antipsychotic Agents, Central Nervous System Diseases, Clinical Therapy, Olanzapine, QuetiapineView official trial listing → -
Completed NCT NCT05039489
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
Not yet reported Central South University 200 participants Est. completion 2023-11-30 1 site Stand-aloneOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05110157
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Not yet reported Neurocrine Biosciences 442 participants Est. completion 2025-02-18 87 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT05146245
Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT
Not yet reported Erasmus Medical Center 140 participants Est. completion 2024-05 1 siteOther conditions: Autism Spectrum DisorderView official trial listing → -
Enrolling by invitation NCT NCT05165316
European Long-acting Antipsychotics in Schizophrenia Trial-II
Rene Kahn 400 participants Est. completion 2026-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05281640
Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial
Not yet reported Edinburgh Napier University 57 participants Est. completion 2023-08-31 2 sitesOther conditions: Psychosis, Complex Post-Traumatic Stress Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT05326347
A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
Not yet reported Otsuka Pharmaceutical Co., Ltd. 247 participants Est. completion 2025-09-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05356013
Caplyta in Borderline Personality Disorder
Not yet reported University of Chicago 60 participants Est. completion 2025-12-31 1 siteOther conditions: Borderline Personality DisorderView official trial listing → -
Completed NCT NCT05390736
Evaluating the Cost Effectiveness of STEADI
Not yet reported National Opinion Research Center 780 participants Est. completion 2023-09-18 1 siteOther conditions: Accidental FallView official trial listing → -
Not yet recruiting NCT NCT05416658
Shared Decision Making for Antipsychotic Medications
Not yet reported New York State Psychiatric Institute 120 participants Est. completion 2027-06-30Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Delusional Disorder, Other Specified Schizophrenia Spectrum and Other Psychotic DisorderView official trial listing → -
Completed NCT NCT05422131
Clozapine Therapy Sample Collection - Method Comparison Study
Saladax Biomedical, Inc. 153 participants Est. completion 2023-05-16 1 siteOther conditions: Patients Prescribed ClozapineView official trial listing → -
Completed NCT NCT05461885
Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial
Not yet reported Copenhagen University Hospital, Rigshospitalet 226 participants Est. completion 2026-01-04 4 sitesOther conditions: Affective Disorder, PsychosisView official trial listing → -
Completed NCT NCT05463770
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 15 participants Est. completion 2023-08-22 8 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT05537558
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
University Hospital Muenster 300 participants Est. completion 2024-01-09 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT05542264
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 19 participants Est. completion 2024-02-12 4 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT05554627
VA Aripiprazole vs Esketamine for Treatment Resistant Depression
Not yet reported VA Office of Research and Development Est. completion 2023-10-27 26 sitesOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT05628103
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 101 participants Est. completion 2024-04-01 25 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT05646264
A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
Not yet reported Shanghai Mental Health Center 220 participants Est. completion 2023-08-01 1 site Stand-aloneOther conditions: Schizophrenia, Negative Symptoms in SchizophreniaView official trial listing → -
Completed NCT NCT05650788
Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects
Not yet reported University Hospital, Clermont-Ferrand 60 participants Est. completion 2024-07-17 1 siteOther conditions: Bipolar Disorder Type II, Mood Depressive DisorderView official trial listing → -
Completed NCT NCT05716802
Dance/Movement Therapy for Bone Mineral Density in Schizophrenia
Not yet reported Hebei Province Veterans Hospital 60 participants Est. completion 2022-07-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT05741502
An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine
Not yet reported Ohio State University 5 participants Est. completion 2026-01-23 1 siteOther conditions: Treatment-resistant SchizophreniaView official trial listing → -
Active, not recruiting NCT NCT05748990
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
Not yet reported Centre for Addiction and Mental Health 20 participants Est. completion 2026-12-31 1 siteOther conditions: Schizophrenia, HealthyView official trial listing → -
Completed NCT NCT05838625
Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia
Not yet reported Click Therapeutics, Inc. 464 participants Est. completion 2025-07-23 54 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT05890768
Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine
Not yet reported University of New Mexico Est. completion 2024-02-28 1 siteOther conditions: PsychosisView official trial listing → -
Status unknown NCT NCT05964790
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
Not yet reported, Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 112 participants Est. completion 2024-12-30Other conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT06060886
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
Not yet reported Consorcio Centro de Investigación Biomédica en Red (CIBER) 244 participants Est. completion 2025-12-31MASLD Other conditions: Schizophrenia, Treatment-resistant Schizophrenia, Side Effect, Lipid Metabolism Disorders, Diabetes, PsychosisView official trial listing → -
Completed NCT NCT06067984
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia
Not yet reported Click Therapeutics, Inc. 73 participants Est. completion 2025-08-22 1 siteOther conditions: Schizophrenia, Negative Symptoms in SchizophreniaView official trial listing → -
Status unknown NCT NCT06107322
Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 Receptors
University Hospital, Strasbourg, France 20 participants Est. completion 2024-03-23 1 siteOther conditions: NeutropeniaView official trial listing → -
Status unknown NCT NCT06159322
Characterizing Response to Antipsychotics in Schizophrenia
The Royal Ottawa Mental Health Centre 40 participants Est. completion 2024-01-30 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT06179108
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
Not yet reported LB Pharmaceuticals Inc. 359 participants Est. completion 2024-12-04 25 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT06236451
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 60 participants Est. completion 2025-11-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT06238089
Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales
University of Plymouth 600 participants Est. completion 2024-04 8 sitesOther conditions: Intellectual DisabilityView official trial listing → -
Active, not recruiting NCT NCT06245213
A Study of ANAVEX3-71 in Adults With Schizophrenia
Not yet reported Anavex Life Sciences Corp. 71 participants Est. completion 2025-06-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Active, not recruiting NCT NCT06251635
Effects of Antipsychotics on Brain Insulin Action in Females
Not yet reported Centre for Addiction and Mental Health 15 participants Est. completion 2026-12-31 1 siteType 2 diabetes Other conditions: Insulin Resistance, Menstrual Cycle, AntipsychoticsView official trial listing → -
Status unknown NCT NCT06274255
Serum Magnesium Level and Pediatric Migraine
Mersin University 60 participants Est. completion 2024-05-15 4 sitesOther conditions: Migraine, Magnesium, PediatricView official trial listing → -
Active, not recruiting NCT NCT06278246
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography
Centre for Addiction and Mental Health 58 participants Est. completion 2026-03 1 siteOther conditions: Schizophrenia, Schizophreniform DisordersView official trial listing → -
Status unknown NCT NCT06294353
Study of Efficacy and Safety of WELT-ED for Eating Disorder (WCTP-ED-B-01)
Not yet reported WELT corp 134 participants Est. completion 2024-08-30 2 sitesOther conditions: Eating Disorders, Binge Eating, Binge-Eating DisorderView official trial listing → -
Status unknown NCT NCT06301074
The Phase I Study of HS-10509 in Chinese Adult Subjects
Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 80 participants Est. completion 2024-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT06326840
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
Not yet reported Taipei Medical University Hospital 42 participants Est. completion 2011-06-10 1 siteOther conditions: Metabolic Disturbance, Hyperprolactinemia, SchizophreniaView official trial listing → -
Completed NCT NCT06331520
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens
Not yet reported Fudan University 644 participants Est. completion 2025-08-30 1 siteOther conditions: Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic ChemotherapyView official trial listing → -
Active, not recruiting NCT NCT06357195
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Ohio State University 1000 participants Est. completion 2026-07-01 1 siteOther conditions: Emergency Psychiatric, Cognition Disorder, Movement Disorders, Antipsychotics and Neuroleptics Toxicity, Dementia With Lewy Bodies, Alteration in Mental Status, Behavior, AgingView official trial listing → -
Completed NCT NCT06410508
Evaluation of a Brief Intervention to Improve Engagement in Early Intervention Services for Psychosis
Not yet reported Nova Scotia Health Authority 33 participants Est. completion 2026-05-22 1 siteOther conditions: Psychotic Disorders, Psychiatric Hospitalization, Engagement, PatientView official trial listing → -
Active, not recruiting NCT NCT06474195
Cue-based Intervention in Prospective Memory and Medication Adherence.
Not yet reported University of Pittsburgh 104 participants Est. completion 2026-09-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Enrolling by invitation NCT NCT06558201
Open Label Extension Study of NCT06221852
Not yet reported Mclean Hospital 50 participants Est. completion 2027-12-30 1 siteOther conditions: Bipolar I Disorder, Schizoaffective Disorder, PsychosisView official trial listing → -
Status unknown NCT NCT06643871
Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis
Not yet reported Centre Hospitalier St Anne 40 participants Est. completion 2025-12-01Other conditions: Schizophrenia; Psychosis, Schizo Affective Disorder, First Episode Psychosis (FEP)View official trial listing → -
Not yet recruiting NCT NCT06695676
Effects of Lurasidone on Left Ventricle Systolic Functions
Aydin Adnan Menderes University 62 participants Est. completion 2025-06-01 1 siteOther conditions: Lurasidone Cardiotoxicity, Schizophrenia Patients, Bipolar DisordersView official trial listing → -
Status unknown NCT NCT06703827
Effects of Online Metacognitive Training Group on Distressing Beliefs
Not yet reported City, University of London 72 participants Est. completion 2025-09-27 1 siteOther conditions: PsychosisView official trial listing → -
Completed NCT NCT06787781
Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects
Not yet reported University of Messina 15 participants Est. completion 2021-12-31 1 siteOther conditions: Metabolic Evaluation, Cardiac ComplicationsView official trial listing → -
Completed NCT NCT06807242
Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )
Oslo University Hospital 270 participants Est. completion 2019-12 1 siteOther conditions: Schizophrenic Psychoses, Schizophrenia, Severe Mental DisorderView official trial listing → -
Active, not recruiting NCT NCT06838104
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial
Not yet reported Lahore General Hospital 76 participants Est. completion 2025-06-05 1 siteOther conditions: Schizophrenia Disorders, Psychotic DisorderView official trial listing → -
Completed NCT NCT06993662
The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.
Not yet reported Rakitzi, Stavroula 107 participants Est. completion 2026-08-03 1 siteOther conditions: Anxiety, Depression, Obsessive-compulsive Disorder, Personality Disorder, Bipolar Disorder, Schizophrenia, Psychotic Disorders, PTSDView official trial listing → -
Not yet recruiting NCT NCT07011693
Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression（SMART-I)
Not yet reported Xinyu Zhou 400 participants Est. completion 2027-12 1 siteOther conditions: Major Depressive Disorder (MDD)View official trial listing → -
Not yet recruiting NCT NCT07024303
Measurement of Treatment Effects
Not yet reported Matthew J O'Brien, PhD, BCBA-D 20 participants Est. completion 2027-12-31Other conditions: Challenging Behavior, Autism Spectrum DisorderView official trial listing → -
Completed NCT NCT07102069
Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia
Tianjin Anding Hospital 384 participants Est. completion 2022-09-14 1 siteOther conditions: SchizophreniaView official trial listing → -
Enrolling by invitation NCT NCT07162467
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
Tianjin Anding Hospital 200 participants Est. completion 2026-06-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07252752
Dopamine and Insulin in Psychosis
Not yet reported Medical University of Vienna 46 participants Est. completion 2029-01-01 1 siteOther conditions: First Episode Psychosis (FEP)View official trial listing → -
Completed NCT NCT07392489
Decreasing Harms and Improving Child Health
Not yet reported Glyn Jones-Elwyn 31 participants Est. completion 2025-02-12 4 sitesOther conditions: Psychotropic Drugs, Psychiatric Drugs, Children, Shared Decision Making, Patient Decision AidView official trial listing → -
Completed NCT NCT07432763
Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia
Not yet reported Panhellenic Federation of Alzheimer's Disease and Related Disorders 18 participants Est. completion 2024-10-31 1 siteOther conditions: Urinary Tract Infections (UTIs), Urinary Tract Infection, Recurrent, Antipsychotics Discontinuation, Antipsychotics TaperingView official trial listing → -
Not yet recruiting NCT NCT07445802
Medication Adherence in Severe Mental Illness: a Promotion Program
Not yet reported Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 1640 participants Est. completion 2028-09Other conditions: Treatment Adherence and Compliance, Severe Mental Disorders, Bipolar Disorder (BD), Schizophrenia DisorderView official trial listing → -
Not yet recruiting NCT NCT07515222
Efficacy of Yoga-Based Intervention in Improving Mother-Child Bonding in Maternal Depression
Not yet reported All India Institute of Medical Sciences 52 participants Est. completion 2027-05-15Other conditions: Perinatal Depression, Postpartum Depression, Mother-Infant Bonding DisorderView official trial listing → -
Completed NCT NCT07541157
Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients
Not yet reported Hasanuddin University 80 participants Est. completion 2026-01-31 1 siteOther conditions: Schizophrenia PatientsView official trial listing → -
Not yet recruiting NCT NCT07548489
Phenobarbital for Agitated Delirium
Not yet reported Duke University 150 participants Est. completion 2027-07 1 siteOther conditions: Agitated Delirium, Delirium Confusional State, Delirium in the Intensive Care Unit, Hyperactive DeliriumView official trial listing → -
Not yet recruiting NCT NCT07570875
Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area
Not yet reported University of Alabama at Birmingham 100 participants Est. completion 2027-11 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Not yet recruiting NCT NCT07715253
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia
Not yet reported New York State Psychiatric Institute 100 participants Est. completion 2030-11-30Other conditions: Schizoaffective Disorder, Schizophreniform Disorder, SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07770282
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 600 participants Est. completion 2030-12-30Metabolic syndrome Other conditions: Schizophrenia Disorder, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin ResistanceView official trial listing → -
Not yet recruiting NCT NCT07802158
Discontinuing Psychotropic Medication Before Psychotherapy for PTSD
Academic Centre for Dentistry in Amsterdam 100 participants Est. completion 2026-09-02Other conditions: Post-traumatic Stress Disorder (PTSD)View official trial listing → -
Not yet recruiting NCT NCT07805980
A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia
Not yet reported Second Xiangya Hospital of Central South University 30 participants Est. completion 2027-06-01 1 siteOther conditions: Schizophrenia, Antipsychotic Induced Weight GainView official trial listing → -
Not yet recruiting NCT NCT07820553
Building a Computational Model of Auditory Hallucinations
King's College London 146 participants Est. completion 2030-08Other conditions: Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophreni-form DisorderView official trial listing → -
Not yet recruiting NCT NCT07822295
The Effect of Chronic ssrı/snrı Antidepressant Treatment on Propofol Consumption in Elective Spine Surgery
Kocaeli City Hospital 216 participants Est. completion 2027-05-30 1 siteOther conditions: Chronic SSRI/SNRI Use and Intraoperative Propofol RequirementsView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.